
KdT Ventures
Description
KdT Ventures is an early-stage venture capital firm headquartered in Austin, Texas, specializing in investments at the intersection of data, engineering, and biology. The firm primarily targets companies from the Seed to Series A stages, seeking to back innovative startups that leverage deep technological insights to solve complex problems. Their investment thesis centers on identifying foundational technologies and scientific breakthroughs that can drive significant advancements across various industries, from healthcare and biotech to advanced manufacturing and AI.
The firm's strategic focus allows them to support founders building disruptive solutions in areas such as synthetic biology, machine learning applications for scientific discovery, and novel engineering platforms. KdT Ventures prides itself on providing more than just capital, offering strategic guidance and access to a robust network of industry experts and scientific advisors. They look for companies with strong technical teams and proprietary technology poised for significant market impact.
KdT Ventures has demonstrated a steady growth in its capital base, successfully closing its second fund, KdT Ventures Fund II, at $100 million in 2021. This followed their inaugural fund, KdT Ventures Fund I, which closed at $40 million in 2019. This capital enables them to make initial investments typically ranging from $500,000 up to $5 million, depending on the stage and needs of the company. Their portfolio reflects a commitment to long-term partnerships with companies that are pushing the boundaries of scientific and technological innovation.
Investor Profile
KdT Ventures has backed more than 79 startups, with 8 new investments in the last 12 months alone. The firm has led 6 rounds, about 8% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel, Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
- Typical check size: $500K – $5M.
Stage Focus
- Seed (49%)
- Series A (34%)
- Series B (9%)
- Convertible Note (3%)
- Series C (1%)
- Pre Seed (1%)
- Series Unknown (1%)
- Series E (1%)
Country Focus
- United States (94%)
- Israel (1%)
- Switzerland (1%)
- United Kingdom (1%)
- India (1%)
- Canada (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Artificial Intelligence (Ai)
- Life Science
- Therapeutics
- Health Diagnostics
- Biopharma
- Manufacturing
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.